Ustekinumab trials for Ulcerative colitis

All Ustekinumab trials · All Ulcerative colitis trials

Phase breakdown

Recruiting trials studying Ustekinumab for Ulcerative colitis

• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
  NCT04372108 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
  NCT03167437 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06453317 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Ustekinumab for Ulcerative colitis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.